Effectiveness and Safety of Fulvestrant in Postmenopausal Women With Advanced Breast Cancer HR+, HER2-

NCT05140655 · clinicaltrials.gov ↗

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasm Female

Interventions

DRUG: Fulvestrant

Sponsor

Dr. Reddy's Laboratories SAS